Bionano Genomics Inc Sees to Have Reduced Annualized Non-Gaap Operating Expenses by About $65.0 to $75.0 Mln by Q1 2025
Bionano Genomics Inc预计到2025年第一季度已将年化非公认会计准则运营支出减少约6,500万美元,至7,500万美元
Bionano Genomics Inc Sees to Have Reduced Annualized Non-Gaap Operating Expenses by About $65.0 to $75.0 Mln by Q1 2025
Bionano Genomics Inc预计到2025年第一季度已将年化非公认会计准则运营支出减少约6,500万美元,至7,500万美元
使用浏览器的分享功能,分享给你的好友吧